Chula Vista Scamster Gets Pinched
Great detective work by the SEC on this. If you ever wonder how/why your stock or stock you're following drops from $1.00...
Revive Therapeutics (RVVTF) Enters the Danger Zone.
What Danger You Ask?
Danger #1, the FDA doesn't like the data, and you own the stock.
Adding Provention Bio (PRVB) $4.60 to 2022 Biotech Watch List.
This is in our 'Stocks we Hope to Double' Watch List.
LIVE QUOTE
AI and Machine Learning Start-Up Nowigence (NWGO) Announces Deal With EquiPPP Technologies (NSE: EQIPPP).
Nowigence CEO Anoop Bhatia was voted most innovative AI NLP Company CEO 2020.With over two decades in various GE companies across different...
Bill Hwang Had $20 Billion, Then Lost It All in Two Days (Bloomberg).
With all the news on leveraged Bitcoin blowups being reported, let's not forget leverage can blowup an Equity portfolio too. Forgotten in...
Provention (PRVB) Price Target $18.
Headline Says Downgrade, But That's Near 300% Higher From Here!
LIVE QUOTE
Smart for Life (SMFL) Capitulates?
We Are Long Term Bullish on Smart for Life. After a Volatile Post IPO Trading, we may Have Seen the Bottom....
Althira (ATHA) $2.50, is Latest Alzheimer’s Trial Victim. Down 70%
Nearly 100 Alzheimer’s programs have failed in the past decade.
Biotech investors should study or at least become...
Novogratz Remains Steadfast on Crypto, Says Wait Until Next Year (Bloomberg)
Great call. This was actually from Late 2018.
(Bloomberg) — Billionaire investor Michael Novogratz is resolute when it...
Ehave, Inc. Announces its KetaDASH Mobile Unit Delivered to Miami Beach.
MIAMI, June 03, 2022 (GLOBE NEWSWIRE) — Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced...
Latest article
Bavarian Nordic (BVNRY) Freeze Dries its MPOX Vaccine!
This is Big News, Honestly. We Are Adding to 2025 Watch List @ $7.36.
We last added Bavarian to...
Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.’s ‘Misinformation And Lies’ (IBD)
Sorting Through the Wreckage!
Full post on Investor's Business Daily.
Biotech stocks took a beating Monday...
